Cargando…

Effects of the selective orexin-2 receptor antagonist JNJ-48816274 on sleep initiated in the circadian wake maintenance zone: a randomised trial

The effects of orexinergic peptides are diverse and are mediated by orexin-1 and orexin-2 receptors. Antagonists that target both receptors have been shown to promote sleep initiation and maintenance. Here, we investigated the role of the orexin-2 receptor in sleep regulation in a randomised, double...

Descripción completa

Detalles Bibliográficos
Autores principales:	Revell, Victoria L., della Monica, Ciro, Mendis, Jeewaka, Hassanin, Hana, Halter, Robin J., Chaplan, Sandra R., Dijk, Derk-Jan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8782905/ https://www.ncbi.nlm.nih.gov/pubmed/34628482 http://dx.doi.org/10.1038/s41386-021-01175-3

Ejemplares similares

Translational evaluation of novel selective orexin-1 receptor antagonist JNJ-61393215 in an experimental model for panic in rodents and humans
por: Salvadore, Giacomo, et al.
Publicado: (2020)

Contactless and longitudinal monitoring of nocturnal sleep and daytime naps in older men and women: a digital health technology evaluation study
por: Ravindran, Kiran K G, et al.
Publicado: (2023)

Three Contactless Sleep Technologies Compared With Actigraphy and Polysomnography in a Heterogeneous Group of Older Men and Women in a Model of Mild Sleep Disturbance: Sleep Laboratory Study
por: G Ravindran, Kiran K, et al.
Publicado: (2023)

The selective orexin-2 antagonist seltorexant (JNJ-42847922/MIN-202) shows antidepressant and sleep-promoting effects in patients with major depressive disorder
por: Recourt, Kasper, et al.
Publicado: (2019)

Evaluation of JNJ-54717793 a Novel Brain Penetrant Selective Orexin 1 Receptor Antagonist in Two Rat Models of Panic Attack Provocation
por: Bonaventure, Pascal, et al.
Publicado: (2017)

Correction to: The selective orexin-2 antagonist seltorexant (JNJ-42847922/MIN-202) shows antidepressant and sleep-promoting effects in patients with major depressive disorder
por: Recourt, Kasper, et al.
Publicado: (2019)

Hypocretin (orexin) regulation of sleep-to-wake transitions
por: de Lecea, Luis, et al.
Publicado: (2014)

Orexin, orexin receptor antagonists and central cardiovascular control
por: Carrive, Pascal
Publicado: (2013)

Prognostication in Advanced Cancer by Combining Actigraphy-Derived Rest-Activity and Sleep Parameters with Routine Clinical Data: An Exploratory Machine Learning Study
por: Patel, Shuchita Dhwiren, et al.
Publicado: (2023)

Machine‐learning‐derived sleep–wake staging from around‐the‐ear electroencephalogram outperforms manual scoring and actigraphy
por: Mikkelsen, Kaare B., et al.
Publicado: (2018)

Circadian rhythm and sleep-wake systems share the dynamic extracellular synaptic milieu
por: Cooper, Joanna M., et al.
Publicado: (2018)

Differential Roles of Orexin Receptors in the Regulation of Sleep/Wakefulness
por: Mieda, Michihiro, et al.
Publicado: (2013)

THE REGULATION OF SLEEP AND WAKEFULNESS BY THE HYPOTHALAMIC NEUROPEPTIDE OREXIN/HYPOCRETIN
por: INUTSUKA, AYUMU, et al.
Publicado: (2013)

Orexin receptor antagonist-induced sleep does not impair the ability to wake in response to emotionally salient acoustic stimuli in dogs
por: Tannenbaum, Pamela L., et al.
Publicado: (2014)

Preclinical in vivo characterization of lemborexant (E2006), a novel dual orexin receptor antagonist for sleep/wake regulation
por: Beuckmann, Carsten Theodor, et al.
Publicado: (2019)

Pharmacogenetic Modulation of Orexin Neurons Alters Sleep/Wakefulness States in Mice
por: Sasaki, Koh, et al.
Publicado: (2011)

The effects of diurnal intermittent fasting on the wake-promoting neurotransmitter orexin-A
por: Almeneessier, Aljohara S., et al.
Publicado: (2018)

Effects of a newly developed potent orexin-2 receptor-selective antagonist, compound 1 m, on sleep/wakefulness states in mice
por: Etori, Keishi, et al.
Publicado: (2014)

Opportunities and perspectives for developing orexin receptor antagonists
por: Steiner, Michel A., et al.
Publicado: (2014)

Orexin receptor antagonists as therapeutic agents for insomnia
por: Equihua, Ana C., et al.
Publicado: (2013)

Circadian and dark-pulse activation of orexin/hypocretin neurons
por: Marston, Oliver J, et al.
Publicado: (2008)

Hypocretin/Orexin Neuropeptides: Participation in the Control of Sleep-Wakefulness Cycle and Energy Homeostasis
por: Nuñez, A, et al.
Publicado: (2009)

The physiological role of orexin/hypocretin neurons in the regulation of sleep/wakefulness and neuroendocrine functions
por: Inutsuka, Ayumu, et al.
Publicado: (2013)

Neurons containing orexin or melanin concentrating hormone reciprocally regulate wake and sleep
por: Konadhode, Roda Rani, et al.
Publicado: (2015)

Dataset of eyeblink conditioning in mice treated with the selective mGluR1 antagonist JNJ16259685
por: Tohyama, Shoichi, et al.
Publicado: (2023)

Orexin antagonists for neuropsychiatric disease: progress and potential pitfalls
por: Yeoh, Jiann Wei, et al.
Publicado: (2014)

Suvorexant: The first orexin receptor antagonist to treat insomnia
por: Dubey, Ashok K., et al.
Publicado: (2015)

Circadian actions of orexins on the retinorecipient lateral geniculate complex in rat
por: Chrobok, Lukasz, et al.
Publicado: (2020)

Orexin Receptor Blockade-Induced Sleep Preserves the Ability to Wake in the Presence of Threat in Mice
por: Iwakawa, Shouhei, et al.
Publicado: (2019)

Kinetic properties of “dual” orexin receptor antagonists at OX(1)R and OX(2)R orexin receptors
por: Callander, Gabrielle E., et al.
Publicado: (2013)

Orexin-1 and orexin-2 receptor antagonists reduce ethanol self-administration in high-drinking rodent models
por: Anderson, Rachel I., et al.
Publicado: (2014)

Light, Sleep, and Circadian Rhythms: Together Again
por: Dijk, Derk-Jan, et al.
Publicado: (2009)

Functional Magnetic Resonance Imaging Reveals Different Neural Substrates for the Effects of Orexin-1 and Orexin-2 Receptor Antagonists
por: Gozzi, Alessandro, et al.
Publicado: (2011)

A Selective Histamine H4 Receptor Antagonist, JNJ7777120, Role on glutamate Transporter Activity in Chronic Depression
por: Yeni, Yesim, et al.
Publicado: (2022)

Serotonergic Input to Orexin Neurons Plays a Role in Maintaining Wakefulness and REM Sleep Architecture
por: Saito, Yuki C., et al.
Publicado: (2018)

Evaluation of SAMP8 Mice as a Model for Sleep-Wake and Rhythm Disturbances Associated with Alzheimer’s Disease: Impact of Treatment with the Dual Orexin (Hypocretin) Receptor Antagonist Lemborexant
por: Beuckmann, Carsten T., et al.
Publicado: (2021)

Circadian and wakefulness-sleep modulation of cognition in humans
por: Wright, Kenneth P., et al.
Publicado: (2012)

Treatment of Circadian Rhythm Sleep–Wake Disorders
por: Sun, Shi-Yu, et al.
Publicado: (2022)

Wake-promoting effects of vagus nerve stimulation after traumatic brain injury: upregulation of orexin-A and orexin receptor type 1 expression in the prefrontal cortex
por: Dong, Xiao-yang, et al.
Publicado: (2018)

Novel Approaches for Assessing Circadian Rhythmicity in Humans: A Review
por: Dijk, Derk-Jan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_p8sbbepl078so9j7u8p5p35sor